ConductScience.org, home

Paper9728893

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.

Gorski JC and 5 others. Clin Pharmacol Ther, 1998. Cited by 350 papers, by iCite.

Cite this record

ConductScience Library. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Papers, record 9728893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9728893

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
350
iCite
Relative citation ratio, by iCite
13.2
iCite
Revised in PubMed
2022-04-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gorski JCJ C
2Jones DRD R
3Haehner-Daniels BDB D
4Hamman MAM A
5O'Mara EM JrE M
6Hall SDS D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
Anti-Bacterial AgentsMajor topic
Aryl Hydrocarbon HydroxylasesMajor topic
ClarithromycinMajor topic
Cytochrome P-450 Enzyme SystemMajor topic
IntestinesMajor topic
LiverMajor topic
MidazolamMajor topic
Oxidoreductases, N-DemethylatingMajor topic
Adult
Biological Availability
Cytochrome P-450 CYP3A
Drug Administration Schedule
Drug Interactions
Female
Humans
Male
Reference Values
Sex Characteristics

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AG13718NIA NIH HHSUnited StatesR01AG013718PubMed and NIHNIH RePORTER
M01 RR00750NCRR NIH HHSUnited StatesM01RR000750PubMed and NIHNIH RePORTER
T32GM08425NIGMS NIH HHSUnited StatesT32GM008425PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 350 citations.

PMIDTitleJournalYearIn PapersSource
42399716Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42399716PubMed
42357334CYP3A-Mediated Metabolism of Zastaprazan in Humans and Associated Drug-Drug Interactions.Pharmaceutics2026https://conductscience.org/library/papers/42357334PubMed
41369158Method development and validation for simultaneous analysis of four bile acids as CYP3A drug-drug interaction biomarkers.Bioanalysis2025https://conductscience.org/library/papers/41369158PubMed
41270461Canine duodenal organoids as a functional platform for intestinal CYP regulation and drug metabolism studies.Drug Metab Dispos2025https://conductscience.org/library/papers/41270461PubMed
41117965Biological sex differences in pharmacokinetics and adverse drug reactions.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41117965PubMed
40869119Natural Polymorphic Variants in the CYP450 Superfamily: A Review of Potential Structural Mechanisms and Functional Consequences.Int J Mol Sci2025https://conductscience.org/library/papers/40869119PubMed
40136716Sexual Dimorphism in Cardiometabolic Diseases: From Development to Senescence and Therapeutic Approaches.Cells2025https://conductscience.org/library/papers/40136716PubMed
39313741Pharmacokinetic Model of Drug Interaction of Tacrolimus with Combined Administration of CYP3A4 Inhibitors Voriconazole and Clarithromycin After Bone Marrow Transplantation.Eur J Drug Metab Pharmacokinet2024https://conductscience.org/library/papers/39313741PubMed
39072249Sedation reversal trends at outpatient ambulatory endoscopic center vs in-hospital ambulatory procedure center using a triage protocol.World J Gastrointest Endosc2024https://conductscience.org/library/papers/39072249PubMed
37361220Pharmacokinetic interaction of voriconazole and clarithromycin in Pakistani healthy male volunteers: a single dose, randomized, crossover, open-label study.Front Pharmacol2023https://conductscience.org/library/papers/37361220PubMed
36611556What Is Known about Midazolam? A Bibliometric Approach of the Literature.Healthcare (Basel)2022https://conductscience.org/library/papers/36611556PubMed
36210839Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker.Front Pharmacol2022https://conductscience.org/library/papers/36210839PubMed
35903521Sedation level with midazolam: A pediatric surgery approach.Saudi Pharm J2022https://conductscience.org/library/papers/35903521PubMed
34783193Physiologically-based pharmacokinetic modeling to predict CYP3A4-mediated drug-drug interactions of finerenone.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/34783193PubMed
34383278Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34383278PubMed
34003603The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs.Pharmacol Res Perspect2021https://conductscience.org/library/papers/34003603PubMed
33572963Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells.Pharmaceutics2021https://conductscience.org/library/papers/33572963PubMed
32973880Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans.Front Genet2020https://conductscience.org/library/papers/32973880PubMed
32725383Volume of Distribution is Unaffected by Metabolic Drug-Drug Interactions.Clin Pharmacokinet2021https://conductscience.org/library/papers/32725383PubMed
32244748The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions.Pharmaceutics2020https://conductscience.org/library/papers/32244748PubMed

See all 108 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9728893

GET https://conductscience.org/api/papers/v1/9728893/cited_by?page=2